Patent filed for Nitric Oxide Delivery Device that is comparable to inhalers for single or short-term usage
07. Januar 2020 06:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), National Investment Bankers Association (NIBA) presenter Nu-Med Plus, Inc., a medical device development company...
Nu-Med Plus Presents at the 147th National Investment Banking Association Conference on November 12-13, 2019 in New York City
03. Dezember 2019 05:30 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), announced today that the Company attended and presented at the 147th National Investment Banking Association (NIBA)...
Nu-Med Plus, Inc. Fast-Tracked Development Plan for Nitric Oxide Delivery Device Gaining Momentum
23. Oktober 2019 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the...
Nu-Med Plus Reports Spike in International Interest from Physicians, Distributors, and Potential Strategic Partners
03. April 2019 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, April 03, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, reports an increase in strategic...
Nu-Med Plus, Inc. Produces New, Smaller, and Smarter Inhaled Nitric Oxide Delivery Unit for Clinical Settings
05. Februar 2019 05:30 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology will receive its first clinical unit...
Nu-Med Plus, Inc. President Helps Lead Call for New Innovation in Inhaled Nitric Oxide Industry
04. Dezember 2018 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, released an open letter from Nu-Med Plus...
Nu-Med Plus, Inc. Announces Strategic Rebrand to Focus on Leading Advancements in the Nitric Oxide Delivery Industry
09. Oktober 2018 07:30 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, announces a new articulation of the...
Nu-Med Plus, Inc. announces Vice President of Medical Marketing discusses the exciting future of Nitric Oxide
26. September 2018 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, announces that Dr. Brett Earl, Vice...
Nu-Med Plus, Inc. Announces Prominent Research Lab to Utilize its New Advanced Nitric Oxide Delivery Product for Study
11. September 2018 07:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, announces that Dr. Ronald Day, a...
Nu-Med Plus, Inc. Strategically Positioned After Monopoly-Ending Patent Ruling Opens Nitric Oxide Market
14. August 2018 09:00 ET
|
Nu-Med Plus Inc.
Innovative nitric oxide delivery device company predicting vibrant market for its next-generation products SALT LAKE CITY, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a...